Leading clinical and scientific experts in neurodegenerative diseases and pharmaceutical research supporting Cogstate’s strategy and research
Dr. Bruce Albala joined the University of California Irvine (UCI), School of Medicine (SOM) in December 2019 as the Associate Dean of Innovation and Clinical Trials with an appointment as a Professor in Neurology. He serves as a Director in the Center for Clinical Research (CCR) which is responsible for oversight and implementation of clinical trials within UCI SOM.
Dr. Adam Brickman is a Professor of Neuropsychology at Columbia University Department of Neurology, the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain and the Gertrude H. Sergievsky Center. Dr. Brickman is a Fellow of the American Psychological Association.
Dr. Sharon Cohen is a behavioral neurologist and the medical director of Toronto Memory Program, a community-based medical facility which she established in 1996 for the purpose of enhancing diagnosis and treatment for individuals with Alzheimer’s disease and related disorders. Her memory clinic and dementia research site are among the most active in Canada.
Prof. Craig Ritchie is a Professor of Psychiatry of Ageing at the University of Edinburgh, Director of Edinburgh Centre for Dementia Prevention, and Director of Brain Health Scotland. In 2018, he was elected Chair of Scottish Dementia Research Consortium (SDRC), a network of dementia researchers, policy makers and people living with dementia from across Scotland.
Dr. Kate Papp is an Assistant Professor of Neurology at Harvard Medical School. She works as a Clinical Neuropsychologist in the Department of Neurology at the Brigham and Women’s Hospital and the Massachusetts General Hospital. She serves as the Neuropsychologist for the Massachusetts Alzheimer’s Disease Research Center (MADRC).
Dr. Siemers’ experience in clinical trials of neurodegenerative disease spans over 25 years, with a research focus on the use of biomarkers in investigational drug research, the development of trial designs that fully characterize the effects of investigational drugs on chronic diseases, and more specifically, the development of strategies for treating individuals before the onset of symptoms of neurodegenerative diseases.
Dr. Sietske Sikkes is an associate professor at the Department of Clinical, Neuro and Developmental Psychology at the VU University and the Alzheimer Center Amsterdam of the Amsterdam University Medical Center. Her main mission is to find optimal measurement methods for cognition, everyday functioning and behavior in neurodegenerative disorders, both as early diagnostic markers and markers for disease progression.
Cogstate’s cognitive scientists and statisticians are experienced with all aspects of clinical conduct, from study design to cognitive data interpretation. Meet our team of accomplished neuropsychologists and clinicians.